“…Decreased expression of the cholesterol transporter, ATP-binding cassette transporter A1 (ABCA1), leads to decreased levels of soluble apoE in the brain and increased parenchymal and vascular amyloid deposition in mouse models of AD (Hirsch-Reinshagen, et al, 2005; Koldamoya et al, 2005). In addition, apoE4 expression in particular, appears to increase APP processing and Aβ production both in vitro and in vivo perhaps by interacting with the apolipoprotein E receptor 2 (ApoER2) (Ye et al, 2005; Ho et al, 2006; He et al, 2007). Conversely, APP expression and its gamma secretase-dependent cleavage appear necessary for appropriate expression of lipoprotein receptor, LRP1, and subsequent apoE levels in the brain (Liu et al, 2007).…”